[1] Cashman MD, Martin DK, Dhillon S, et al.Irritable bowel syndrome:a clinical review[J]. CurrRheumatol Rev,2016,12(1):13-26. [2] Kanazawa M, Hongo M, Fukudo S.Visceral hypersensitivity in irritable bowel syndrome[J]. J Gastroenterol Hepatol,2011,26(3):119-121. [3] Nguyen HT, Dalmasso G, Muller S, et al.Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy[J].Gastroenterology,2014,146(2):508-519. [4] Kalla R, Ventham NT, Kennedy NA, et al.MicroRNAs:new players in IBD[J]. Gut,2015,64(3):504-517. [5] Defrees DN, Bailey J.Irritable bowel syndrome:epidemiology,pathophysiology,diagnosis,and treatment[J]. Prim Care,2017,44(4):655-671. [6] Chey WD, Kurlander J, Eswaran S.Irritable bowel syndrome:a clinical review[J]. JAMA,2015,313(9):949-958. [7] Longstreth GF, Thompson WG, Chey WD, et al.Functional bowel disorders[J]. Gastroenterology,2006,130(5):1480-1491. [8] 董智瑀,许树长. 脑源性神经营养因子介导精神应激诱发内脏高敏感的研究进展[J]. 外科研究与新技术,2017,6(3):209-211. [9] Bradford K, Shih W, Videlock EJ, et al.Association between early adverse life events and irritable bowel syndrome[J]. Clin Gastroenterol Hepatol,2012,10(4):385-390. [10] Farzaei MH, Bahramsoltani R, Abdollahi M, et al.The role of visceral hypersensitivity in irritable bowel syndrome:pharmacological targets and novel treatments[J]. J Neurogastroenterol Motil,2016,22(4):558-574. [11] Bartel DP.MicroRNAs:target recognition and regulatory functions[J]. Cell,2009,136(2):215-233. [12] Yu W, Zhu K, Wang Y, et al.Overexpression of miR-21-5p promotes proliferation and invasion of colon adenocarcinoma cells through targeting CHL1[J]. Mol Med,2018,24(1):36. [13] Clancy C, Joyce MR, Kerin MJ.The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer[J].Cancer Biomark,2015,15(2):103-13. [14] Cong M, Shen M, Wu X, et al.Improvement of sensory neuron growth and survival via negatively regulating PTEN by miR-21-5p-contained small extracellular vesicles from skin precursor-derived Schwann cells[J]. Stem Cell Res Ther,2021,12(1):80. [15] Santos F, Cabreira V, Rocha S, et al.Blood biomarkers for the diagnosis of neurodegenerative dementia:a systematic review[J]. J Geriatr Psychiatry Neurol,2023,36(4):267-281. [16] Zhang ZJ, Guo JS, Li SS, et al.TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG[J]. J Exp Med,2018,215(12):3019-3037. [17] Wojtowicz K, Świerczewska M, Nowicki M, et al.The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell lines[J]. Adv Med Sci,2023,68(2):379-385. [18] Chiavarina B, Costanza B, Ronca R, et al.Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.Theranostics[J]. 2021,11(4):1626-1640. [19] Fico F,Santamaria-Martínez A.TGFBI modulates tumour hypoxia and promotes breast cancer metastasis[J].Mol Oncol,2020,14(12):3198-3210. [20] Qiu Z, Ma X, Xie J, et al.miR-1307-5p regulates proliferation and apoptosis of chondrocytes in osteoarthritis by specifically inhibiting transforming growth factor beta-induced gene[J]. Am J Transl Res,2021,13(7):7756-7766. [21] Hong Y, Li Z, Su Y, et al.The ceRNA mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in cell proliferation and apoptosis in bladder cancer[J]. Crit Rev Eukaryot Gene Expr,2024;34(1):55-68. [22] Yan L, Ma J, Wang Y, et al.miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells[J].ExpTher Med,2018,16(6):4655-4663. |